C Finelli;C Clissa; M Follo; D Russo; C Filì; A Curti;S Paolini;
C Bosi; S Mongiorgi; L Manzoli; C Papayannidis; S Parisi;
G Martinelli; L Cocco; M Baccarani, PROLONGED HEMATOLOGIC AND MOLECULAR RESPONSE
AFTER A LIMITED NUMBER OF AZACITIDINE CYCLES IN LOW-RISK
MYELODYSPLASTIC SYNDROMES, in: Abstract Book, «HAEMATOLOGICA», 2011, 96, pp. 348 - 348 (atti di: 16th Congress of the European Hematology Association, LONDON, June 9–12, 2011) [Abstract]
Cocco L; Follo MY; Faenza I; Fiume R; Ramazzotti G; Weber G; Martelli AM; Manzoli FA, Physiology and pathology of nuclear phospholipase C beta1, «ADVANCES IN ENZYME REGULATION», 2011, 51, pp. 2 - 12 [Scientific article]
Evangelisti C; Ricci F; Tazzari P; Chiarini F; Battistelli M; Falcieri E;
Ognibene A; Pagliaro P; Cocco L; McCubrey JA; Martelli AM, Preclinical testing of the Akt inhibitor triciribine in T-cell acute lymphoblastic leukemia, «JOURNAL OF CELLULAR PHYSIOLOGY», 2011, 226, pp. 822 - 831 [Scientific article]
C. Finelli; C. Clissa; M. Follo; A. Curti; S. Paolini; C. Papayannidis; S. Mongiorgi; S. Parisi; L. Manzoli; G. Martinelli; L. Cocco; M. Baccarani, Prolonged low-dose azacitidine schedule in high-risk MDS patients: Hematologic and molecular response, in: Abstracts of the 11th International Symposium on Myelodysplastic Syndromes (MDS), «LEUKEMIA RESEARCH», 2011, 35, pp. S65 - S65 (atti di: 11th International Symposium on Myelodysplastic Syndromes (MDS), EDINBURGH, 18-21 MAGGIO 2011) [Abstract]
Chappell W.H.; Steelman L.S.; Long J.M.; Kempf R.C.; Abrams S.L.; Franklin R.A.; Bäsecke J.; Stivala F.; Donia M.; Fagone P.; Malaponte G.; Mazzarino M.C.; Nicoletti F.; Libra M.; Maksimovic-Ivanic D.; Mijatovic S.; Montalto G.; Cervello M.; Laidler P.; Milella M.; Tafuri A.; Bonati A.; Evangelisti C.; Cocco L.; Martelli A.M.; McCubrey J.A., Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health., «ONCOTARGET», 2011, 2, pp. 135 - 164 [Scientific article]
Maraldi T; Bertacchini J; Benincasa M; Guida M; De Pol A; Liotta LA; Petricoin E; Cocco L; Marmiroli S, Reverse-phase protein microarrays (RPPA) as a diagnostic
and therapeutic guide in multidrug resistant leukemia, «INTERNATIONAL JOURNAL OF ONCOLOGY», 2011, 38, pp. 427 - 435 [Scientific article]
M.Y. Follo; S. Mongiorgi; C. Clissa; C. Bosi; M. Baccarani; G. Martinelli; L. Manzoli; C. Finelli; L. Cocco, Role of inositide signalling regulation in higher-risk MDS patients during epigenetic therapy, in: LEUKEMIA RESEARCH, «LEUKEMIA RESEARCH», 2011, 35, pp. S94 - S95 (atti di: 11th International Symposium on Myelodysplastic Syndromes (MDS), EDINBURGH, 18-21 MAGGIO 2011) [Contribution to conference proceedings]
Steelman L.S.; Chappell W.H.; Abrams S.L.; Kempf R.C.; Long J.; Laidler P.; Mijatovic S.; Maksimovic-Ivanic D.; Stivala F.; Mazzarino M.C.; Donia M.; Fagone P.; Malaponte G.; Nicoletti F.; Libra M.; Milella M.; Tafuri A.; Bonati A.; Bäsecke J.; Cocco L.; Evangelisti C.; Martelli A.M.; Montalto G.; Cervello M.; McCubrey J.A., Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging., «AGING», 2011, 3, pp. 192 - 222 [Scientific article]
Follo MY; Finelli C; Mongiorgi S; Clissa C; Chiarini F; Ramazzotti G; Paolini S; Martinelli G; Martelli AM; Cocco L, Synergistic induction of PI-PLCbeta1
signaling by azacitidine and valproic acid in high-risk myelodysplastic
syndromes, «LEUKEMIA», 2011, 25, pp. 271 - 280 [Scientific article]
Martelli AM; Evangelisti C; Follo MY; Ramazzotti G; Fini M; Giardino R; Manzoli L; McCubrey JA; Cocco L., Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in cancer stem cells, «CURRENT MEDICINAL CHEMISTRY», 2011, 18 (18), pp. 2715 - 2726 [Scientific article]
Ramazzotti G.; Faenza I.; Fiume R.; Matteucci A.; Piazzi M.; Follo MY.; Cocco L., The
physiology and pathology of inositide signaling in the nucleus, «JOURNAL OF CELLULAR PHYSIOLOGY», 2011, 226, pp. 14 - 20 [Scientific article]
James A. McCubrey;Linda S. Steelman;C. Ruth Kempf;William H. Chappell;Stephen L. Abrams;Franca Stivala;Graziella Malaponte;Ferdinando Nicoletti;Massimo Libra;Jörg Bäsecke;Danijela Maksimovic-Ivanic;Sanja Mijatovic;Giuseppe Montalto;Melchiorre Cervello;Lucio Cocco;Alberto M. Martelli, Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways, «JOURNAL OF CELLULAR PHYSIOLOGY», 2011, 226, pp. 2762 - 2781 [Scientific article]
Gaboardi GC; Ramazzotti G; Bavelloni A; Piazzi M; Fiume R; Billi AM; Matteucci A; Faenza I; Cocco L, A role for PKCepsilon during C2C12 myogenic differentiation, «CELLULAR SIGNALLING», 2010, 22, pp. 629 - 635 [Scientific article]
Blalock WL; Bavelloni A; Piazzi M; Faenza I; Cocco L, A role for PKR in
hematologic malignancies, «JOURNAL OF CELLULAR PHYSIOLOGY», 2010, 223, pp. 572 - 591 [Scientific article]
Ruolo editoriale nella rivista «Advances in Enzyme Regulation», AMSTERDAM, Elsevier